Prescribing Pattern of Antifungal Drugs in a Tertiary Care Teaching Hospital in Western India
Abstract
Fungal infections are prevalent in a tropical country like India. Pharmacotherapy of fungal disease has been revolutionized by the introduction of relatively less toxic oral drugs, com- bination therapy, and new formulations of older agents. However, data regarding antifungal drug usage patterns in India must be more present. Hence, this study was planned to study the prescribing pattern and to compare the cost of antifungal drugs in patients attending a tertiary care teaching hospital. It was a cross-sectional, observational study carried out at GCS Hospital, Ahmedabad, from April 2021 to Sept 2021. Prescriptions of 130 patients were collected and analyzed using Microsoft Excel version 2013. A total of 213 antifungal drugs were prescribed to 130 patients. Most patients, 81 (62.3%) were from the 18-40 age group. Combined antifungal treatment (Oral + Topical) was prescribed in 77(59.2%). The most common class of antifungal drugs was imidazole 107 (50.23%), and clotrimazole was the most familiar drug. The most common indication for antifungal therapy was tinea cruris (45.38%). An average of 3.75 drugs were prescribed per prescription, of which 1.63 were antifungal drugs. Combined treatment of oral and topical antifungal drugs was common in dermatological practice. However, the cost of the treatment can be reduced by prescribing generic drugs.
Keywords
Full Text:
PDFReferences
Vegada, B.N. & Karelia, B.N. & Singh, A.P. Drug utilization study of antifungal agents used in department of skin & V.D. of a tertiary care teaching hospital. International Journal of Pharmaceutical Sciences Review and Research.2015; 34:118-121.
Hasim, Sahar, and Jeffrey J Coleman. “Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents.” Future Medicinal Chemistry. 2019; 11(8):869- 883.
Bansal P, Baishnab S, Singla A. Drug prescribing pattern of antifungal drugs for local fungal infections in a tertiary care hospital: MAMC, Agroha. International Journal of Basic and Clinical Pharmacology. 2021; 10:689-93.
Das K, Basak S, Ray S, A Study on Superficial Fungal Infection from West Bengal : A Brief Report. Journal of Life Sciences. 2009; 1(1):51-55.
Naaz R, Chand S, Nandakumar U. P, Vinay B. C, Raj K. C. B, Shetty S. Prospective Observational Study on Prescribing Pattern of Antifungal Drugs in the 400 Out-Patient Department of Dermatology in a Tertiary Care Hospital. Biomedical and Pharmacology Journal. 2021; 14(1):311- 316.
Ghannoum MA, Rice LB. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clinical Microbiology Reviews. 1999; 12(4):501-517.
Islahudin F, Mohd SFR, Lai YK. Evaluation of appropriate use of antifungal therapy in a tertiary care hospital. Asian Journal of Pharmaceuticals and Clinical Research. 2015; 8(4):195-199
Deb P, Mohanty I, Slathia I, Verma V. Drug utilisation and self-medication pattern of anti-fungal drugs in dermatology outpatient department of a tertiary care hospital. International Journal of Basic and Clinical Pharmacology. 2017; 6:2189-2192.
Patil A, Dighe D, Kolte S, Jadhav PR, Deshmukh YA. Drug utilization pattern in dermatology outpatient department at a tertiary care hospital in Navi Mumbai. International Journal of Basic and Clinical Pharmacology. 2017; 6:559-562.
Parvathy G, Sudha MJ, Pillai RT, Ramani PT. A study on the prescription pattern of antifungal drugs in the Dermatology Department of a tertiary care teaching hospital in Southern Kerala. International Journal of Basic and Clinical Pharmacology. 2019; 8:100-3.
Vakade, Kiran & Indurkar, Vishal & Chordia, Aayush. Drug utilization pattern for skin diseases in dermatology opd at tertiary care hospital of western maharashtra. International Journal of Clinical and Biomedical Research.2019; 5(3):20-23.
Ali M, Patel M, Banu N, Ahmad A, Hassan Y. A retrospective study on drug utilization pattern and cost utility analysis of antifungal drugs. Journal of Pharmaceutical Health Services Research. March 2021,12(1);94–97
Al Balushi KA, Alzaabi MA, Alghafri F. Prescribing pattern of antifungal medications at a tertiary care hospital in Oman. Journal of Clinical and Diagnostic Research. 2016; 10(12):27-30.
Manohar M, Singh A. An observational and cross-sectional study of prescribing pattern of antifungal drugs in a tertiary care center of Bihar. IP International Journal of Comprehensive and Advanced Pharmacology 2021; 6(4):177-180.
Fuentefria, A. M., Pippi, B., Dalla Lana, D. F., Donato, K. K., & de Andrade, S. F. Antifungals discovery: an insight into new strategies to combat antifungal resistance. Letters in applied microbiology.2018; 66(1):2–13.
Scorzoni L, de Paula e Silva ACA, Marcos CM, Assato PA, de Melo WCMA, de Oliveira HC, Costa-Orlandi CB, Mendes- Giannini MJS and Fusco-Almeida AM. Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis. Frontiers in Microbiology. 2017; 8:36.
Hatzl, S., Reisinger, A.C., Posch, F. et al. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study. Critical Care. 2021; 25, 335
Rana P, Ghadlinge M, Roy V. Topical antifungal-corticosteroid fixed-drug combinations: Need for urgent action. Indian Journal of Pharmacology. 2021; 53(1):82-84.
Verma S B. Complex Cost Issues in Treating Dermatophytoses in India-”It All Builds Up”. Indian Dermatology Online Journal. 2019; 10(4): 441–443.
Spoorthy HV, Padma L, Srividya BP. Analysis of cost of various topical and oral antifungal drugs for superficial fungal infections available in India. International Journal of Basic Clinical Pharmacology. 2021; 10(12):1348-1351
DOI: https://doi.org/10.15416/pcpr.v8i1.39238
Refbacks
- There are currently no refbacks.
